pharma news

News

Sanofi gets double blow for MS drug tolebrutinib

Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.

News

GSK closes on approval of asthma hope depemokimab

GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.

News

Sobi pays $1.5bn for Arthrosi to grow in gout

Sobi has hit the acquisition trail with a deal to buy Arthrosi Therapeutics for up to $1.5 billion, adding a drug in late-stage testing for gout.

News

CHMP decision levels the playing field for GSK's RSV jab

GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

News

SanegeneBio raises $110m for RNAi, plus other financings

Biotech financings this week include SanegeneBio's Lilly-backed $110m Series B, with Sidera, D3 Bio, BlossomHill, and Prolynx also raising new funds.

Sanofi gets double blow for MS drug tolebrutinib

GSK closes on approval of asthma hope depemokimab

Sobi pays $1.5bn for Arthrosi to grow in gout

CHMP decision levels the playing field for GSK's RSV jab

UK teams up with Singapore on healthtech regulation

SanegeneBio raises $110m for RNAi, plus other financings

UK offers meningitis jab to young people after outbreak

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks